BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 10, 2002
View Archived Issues
Three ZymoGenetics product candidates to enter clinic in the next year
Read More
Good safety profile reported for IL-13-PE38QQR in malignant glioma
Read More
Potential use of gabapentin in glossodynia
Read More
Neuroprotective effects reported for zanapezil in ischemic rats
Read More
Potential use of NO-releasing hydrogel dressing in wound healing
Read More
Induction of Th2 responses reported for rhIL-4 in psoriatic patients
Read More
Novel series of HIV reverse transcriptase inhibitors identified at Pfizer
Read More
Merck designs new NK1 antagonists
Read More
New amlodipine analogue with utility in angina and hypertension
Read More
Aeolus and Duke University claim porphyrin-based antioxidants for pulmonary inflammatory diseases
Read More
Novel ligands of G-protein-coupled receptors covered by Sepracor patent
Read More
Lilly and Boehringer Ingelheim sign cocommercialization agreements for duloxetine
Read More
Millennium to submit Velcade NDA and MAA filings by early 2003
Read More
huN901-DM1 enters phase II portion of U.S. SCLC study
Read More
Curis licenses PYY patents to Amylin for treatment of metabolic diseases
Read More
First phase III alvimopan trial in postoperative ileus completes enrollment
Read More
More obstacles to Pfizer/Pharmacia merger removed
Read More
Orphan drug status sought for thymosin beta 4
Read More
RSD-1235 shows oral bioavailability in humans
Read More
Once-weekly dosing of Enbrel supported by phase III study
Read More
IL-15-targeting antibody superior to ciclosporin in mouse model of psoriasis
Read More
Efalizumab suppresses inflammation-related genes in addition to T-cell migration
Read More
Civacir receives orphan drug status for prevention of hepatitis C
Read More
FDA requests additional clinical data for lercanidipine
Read More
Epimmune files IND for cancer vaccine
Read More
Novo Nordisk submits NDA for NN-304
Read More